The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
about
The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseasesFemale pattern alopecia: current perspectivesPharmacology of anabolic steroidsManagement of hair loss associated with endocrine therapy in patients with breast cancer: an overviewAndrogenetic alopecia: an evidence-based treatment updateWhat Ages Hair?Hormonal therapy in female pattern hair loss.Finasteride induced Gynecomastia: Case report and Review of the Literature5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride.Multi-therapies in androgenetic alopecia: review and clinical experiences.Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic AlopeciaAndrogens and estrogens in benign prostatic hyperplasia: past, present and future.Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA.Treatments options for alopecia.Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study.5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric DisorderEfficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth.Pharmacokinetics and pharmacodynamics of oral testosterone enanthate plus dutasteride for 4 weeks in normal men: implications for male hormonal contraceptionThe role of androgen and androgen receptor in skin-related disorders.Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.Treatment options for alopecia: an update, looking to the future.Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia.The strategies to control prostate cancer by chemoprevention approaches.Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers.Androgenetic Alopecia: An Update of Treatment Options.Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine.Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America.Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway.Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia.Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients.What ages hair?Treatment strategies for alopeciaComparative enzyme inhibition study of 1-deazapurinesHuman umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth
P2860
Q21285041-B64D864A-E15C-4D28-AAA9-396532C0D96CQ24626432-0B77931E-79B9-48A7-905C-7249F9637875Q24650695-D70B84FD-0D0F-4328-922E-0300BAD64E37Q26744259-D5E72C7B-A406-4772-B20B-C0E260F23BAFQ28240536-93CAA84F-7262-4D8C-961E-D118CEDF398AQ33641730-0903A209-920A-45A7-B00C-A2526F69945FQ33641738-457450BC-908B-4324-8467-CDC1B6D6A071Q34089440-65BAF7B5-8A4A-41B2-938A-AED63EF61557Q34183936-A8237C5D-2477-42AA-B105-7C34530ECC56Q34222234-5B50A326-9A7B-4706-B6F6-19C4211145F1Q34313221-66553764-F00E-4FD7-BCB3-C32F26CABFFFQ34350952-5C003313-887C-4006-BED9-D5D69A19B943Q34534360-3D819B7B-E5DB-4DEB-BFA3-2DDAEAC38AE5Q34536368-6BB0A004-B7EC-4CED-9D56-62CC7479E250Q35231660-36B7D54B-959A-49FA-A2B4-9A3653FC9D59Q35684314-76E10F54-2587-4890-9318-08E504602AB3Q35762063-E8976723-FF4B-4872-ACC1-00709FCA1F86Q36050645-C78023DE-5D4A-4104-8FDD-1434EBBA72EFQ36565664-2E62DDB3-8B1B-49E7-899A-9F144133C608Q37144176-6C9CF218-B57F-4D4E-9C51-93A24B69746CQ37147775-F4E36716-34A9-4F28-A698-222E8D845C6AQ37149457-0C49065D-621A-46E9-8D64-76F14F4DC5B6Q37901048-1336DAF7-3C1A-4523-AD46-FBF87F36B2B0Q38010773-041F1BB5-61D0-47DE-AE08-68AFAF6C198AQ38172303-1A07A97C-4068-4E78-B21B-28EBD6A9653DQ38175776-5B045272-92FD-48CE-873D-EFECFA8C313FQ38418380-9C7D771C-A994-414A-BD19-E39098B7E963Q38935324-7D2CA0AE-F08D-47F5-8C64-DE6E9AA9E279Q41008346-F9A9223E-46D3-43F9-8FDF-82909EFEDB27Q41540287-329E3E92-80AA-46C9-A1DC-998339FA41A8Q42688182-D4244A57-3602-4757-A106-96E71AF70F84Q44768432-4A96AF6A-0AC4-4968-9968-CC7BDE5092E1Q46748110-D0416DBC-B124-412E-A628-661E443DC72FQ53063797-94E4CA7D-DE74-450C-98C2-9D547FEB32EDQ54213051-77DEC067-074E-4405-B5C2-5DCCF86EC783Q54855881-A473EE44-5E68-4147-B6B6-5113C069BB0FQ56991024-C8AE6726-24C1-4F0C-B892-F80EE2074119Q58020597-EFC69E4A-48F3-4A2B-9D84-8A6C937BC728Q58700993-4369464E-B6B5-43FD-B7BD-55A56B591A7E
P2860
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The importance of dual 5alpha- ...... utasteride versus finasteride.
@ast
The importance of dual 5alpha- ...... utasteride versus finasteride.
@en
The importance of dual 5alpha- ...... utasteride versus finasteride.
@nl
type
label
The importance of dual 5alpha- ...... utasteride versus finasteride.
@ast
The importance of dual 5alpha- ...... utasteride versus finasteride.
@en
The importance of dual 5alpha- ...... utasteride versus finasteride.
@nl
prefLabel
The importance of dual 5alpha- ...... utasteride versus finasteride.
@ast
The importance of dual 5alpha- ...... utasteride versus finasteride.
@en
The importance of dual 5alpha- ...... utasteride versus finasteride.
@nl
P2093
P1476
The importance of dual 5alpha- ...... utasteride versus finasteride.
@en
P2093
David Whiting
Dow Stough
Dutasteride Alopecia Research Team
Elise A Olsen
Maria Hordinsky
Melissa L Ellis
Roger S Rittmaster
Stuart Hobbs
Timothy Wilson
P304
P356
10.1016/J.JAAD.2006.05.007
P407
P577
2006-12-01T00:00:00Z